Q1 2024 EPS Estimates for Vor Biopharma Inc (NYSE:VOR) Reduced by Wedbush theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Wedbush reiterated their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $11.00 price target on the stock. Wedbush also issued estimates for Vor Biopharma’s Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.24) EPS, Q3 2025 […]
JMP Securities Reaffirms Market Outperform Rating for Vor Biopharma (NYSE:VOR) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Vor Biopharma Inc (NYSE:VOR) Receives $15 19 Average PT from Analysts etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.